The global drug-device combination products market was valued at $81,374 million in 2017 and is projected to reach $139,193 million by 2025 at a CAGR of 6.9% from 2018 to 2025

Friday, November 30, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 29, 2018 /PRNewswire/ -- Drug-Device Combination Products Market by Product (Drug-eluting Stent, Infusion Pump, Photodynamic Therapy, Antimicrobial Wound Dressing, Prefilled Syringe, Drug-eluting Balloon, Nebulizer, Inhaler, Transdermal Delivery System, and Others), Application (Cardiovascular Treatment, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Others), and End User (Hospital & Clinic, Ambulatory Surgical Center, Home Care Setting, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025

Download the full report: Drug-device combination products comprise of two or more regulated components, which work in coordination. These components involve a medical device, which is used to administer
a therapeutic drug in the patient's body. The drug-device combination products can be single products comprising of several components or products packed separately, intended for use with a specialized counterpart. The therapeutic drugs used along with the specific device are either mixed physically or chemically to obtain a resulting mixture for the final use. Currently, the best-known example of drug-device combination product is the drug-eluting stents that are scaffolds coated with a therapeutic drug to prevent growth of tissue scars in an artery.The global drug-device combination products market was valued at $81,374 million in 2017 and is projected to reach $139,193 million by 2025 at a CAGR of 6.9% from 2018 to 2025. Increase in prevalence of chronic diseases such as diabetes, cardiovascular disorders, respiratory problems, and cancer, drive the growth of the global drug-device combination products market. Further, rise in geriatric population, technological advancements in drug-device combination product, and surge in homebased healthcare market are the other factors that boost the market growth. However, stringent governmental regulations for the approval of combination devices and post-complications and errors lead to numerous product recalls that hinder the growth of the global market. On the contrary, rise in healthcare infrastructure and high market potential in untapped emerging economies are anticipated to serve as lucrative opportunities for market expansion.The global drug-device combination products market is segmented based on product, application, end user, and region. Based on product, the market is segmented into drug-eluting stent, infusion pump, photodynamic therapy, antimicrobial wound dressing, prefilled syringe, drug-eluting balloon, nebulizer, inhaler, transdermal delivery system, and other products. Drug-eluting stents are further sub-segmented into coronary drug-eluting stent and peripheral drug-eluting stent. The infusion pumps segment is further divided into implantable infusion pumps, insulin infusion pumps, patient-controlled analgesia pumps, and ambulatory infusion pumps. Similarly, prefilled syringes are further categorized into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. The drug-eluting balloons segment is bifurcated into coronary drug-eluting balloons and peripheral drug-eluting balloons. The inhalers segment is further segmented into drug powder inhalers (DPIs), metered dose inhalers (MDIs), and soft mist inhalers (SMIs). Lastly, transdermal delivery systems segment is divided into passive delivery systems and active delivery systems.As per application, the market is categorized into cardiovascular diseases, diabetes, respiratory problems, cancer treatment, antimicrobial applications, and other applications. Considering the end-user segment, the market is segregated into hospital & clinic, ambulatory surgery center, home care setting, and other end users. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.KEY BENEFITS FOR STAKEHOLDERSThe study provides an in-depth analysis of the global drug-device combination products market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.A comprehensive analysis of factors that drive and restrict the market growth is provided.Factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.Key Market SegmentsBy ProductDrug-eluting stentCoronary drug-eluting stentPeripheral drug-eluting stentInfusion pumpImplantable infusion pumpInsulin infusion pumpPatient-controlled analgesia pumpAmbulatory infusion pumpPhotodynamic therapyAntimicrobial wound dressingPrefilled syringeSingle-chamber prefilled syringeDual-chamber prefilled syringeCustomized prefilled syringeDrug-eluting balloonCoronary drug-eluting balloonPeripheral drug-eluting balloonNebulizerInhalerDrug powder inhaler (DPI)Metered dose inhaler (MDI)Soft mist inhaler (SMI)Transdermal delivery systemPassive delivery systemActive delivery systemOther productsBy ApplicationCardiovascular diseaseDiabetesRespiratory problemCancer treatmentAntimicrobial applicationOther applicationsBy End userHospital & ClinicAmbulatory Surgery Center (ASCs)Home Care SettingOther end usersBy RegionNorth AmericaU.S.CanadaMexicoEuropeGermanyFranceUKItalySpainRest of EuropeAsia-PacificJapanChinaIndiaAustraliaSouth KoreaRest of Asia-PacificLAMEABrazilSaudi ArabiaUAERest of LAMEALIST OF KEY PLAYERS PROFILED IN THE REPORTAbbott LaboratoriesMedtronic PlcSmith & Nephew PlcBoston Scientific CorporationGlaxoSmithKline plcBecton, Dickinson and CompanyJohnson & JohnsonNovartis AGBayer AGBaxter International, Inc.LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiledDownload the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +1 (718) 213 4904 Website:

Cision View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store